UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3998) 3998
Book Chapter (61) 61
Conference Proceeding (25) 25
Publication (15) 15
Dissertation (5) 5
Book Review (1) 1
Government Document (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tolerability (3507) 3507
science & technology (2500) 2500
life sciences & biomedicine (2466) 2466
humans (2234) 2234
male (1483) 1483
female (1468) 1468
adult (1162) 1162
efficacy (1118) 1118
middle aged (1072) 1072
pharmacology & pharmacy (931) 931
safety (893) 893
biological and medical sciences (832) 832
medical sciences (820) 820
treatment outcome (770) 770
aged (733) 733
pharmacology. drug treatments (618) 618
neurosciences & neurology (532) 532
adolescent (509) 509
pharmacokinetics (502) 502
clinical neurology (474) 474
double-blind method (473) 473
psychiatry (379) 379
dose-response relationship, drug (370) 370
drug therapy (363) 363
young adult (349) 349
clinical trials (281) 281
aged, 80 and over (268) 268
analysis (260) 260
care and treatment (258) 258
medicine & public health (238) 238
child (235) 235
drug administration schedule (235) 235
drug therapy, combination (233) 233
internal medicine (229) 229
oncology (227) 227
prospective studies (219) 219
epilepsy (218) 218
neurosciences (217) 217
neurology (199) 199
administration, oral (198) 198
randomized controlled trials as topic (198) 198
animals (192) 192
schizophrenia (185) 185
research (175) 175
follow-up studies (174) 174
quality of life (171) 171
time factors (170) 170
neuropharmacology (166) 166
pharmacodynamics (164) 164
pharmacology (160) 160
medicine, research & experimental (158) 158
research & experimental medicine (158) 158
retrospective studies (157) 157
patients (155) 155
immunology (148) 148
dosage and administration (144) 144
side effects (141) 141
infectious diseases (139) 139
pharmacology/toxicology (139) 139
psychology. psychoanalysis. psychiatry (135) 135
health aspects (134) 134
drug dosages (132) 132
antipsychotic agents - adverse effects (130) 130
anticonvulsants - therapeutic use (129) 129
review (128) 128
clinical trials as topic (126) 126
studies (126) 126
adverse events (125) 125
child, preschool (124) 124
hypertension (124) 124
antipsychotic agents - therapeutic use (123) 123
general & internal medicine (123) 123
medicine, general & internal (122) 122
medical research (121) 121
psychopharmacology (121) 121
area under curve (118) 118
original research (118) 118
effectiveness (115) 115
cross-over studies (113) 113
seizures (108) 108
children (106) 106
schizophrenia - drug therapy (106) 106
depression (105) 105
severity of illness index (105) 105
anticonvulsants - adverse effects (99) 99
chemotherapy (97) 97
medicine (97) 97
risk factors (97) 97
drug tolerance (96) 96
cardiovascular system & cardiology (95) 95
usage (95) 95
drugs (92) 92
pediatrics (92) 92
toxicology (92) 92
antidepressants (91) 91
medicine, experimental (91) 91
hypertension - drug therapy (88) 88
drug combinations (87) 87
migraine (87) 87
cancer (86) 86
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3732) 3732
German (153) 153
Russian (87) 87
Spanish (61) 61
Italian (60) 60
French (43) 43
Portuguese (18) 18
Japanese (14) 14
Czech (12) 12
Polish (12) 12
Turkish (7) 7
Korean (6) 6
Chinese (5) 5
Hungarian (4) 4
Dutch (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AIDS research and therapy, ISSN 1742-6405, 08/2019, Volume 16, Issue 1, pp. 21 - 21
Journal Article
Seizure (London, England), ISSN 1059-1311, 12/2020, Volume 83, pp. 197 - 202
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2013, Volume 49, Issue 16, pp. 3412 - 3419
Hematology, Oncology and Palliative Medicine | Second line | Regorafenib | Hepatocellular carcinoma | Tolerability | Safety | Receptor kinase inhibition | Safety Second line | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Pharmacology. Drug treatments | Tumors | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Liver Neoplasms - mortality | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacokinetics | Phenylurea Compounds - pharmacokinetics | Liver Neoplasms - enzymology | Pyridines - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Pyridines - administration & dosage | Drug Administration Schedule | Europe | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Treatment Outcome | Carcinoma, Hepatocellular - enzymology | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging | Care and treatment | Safety and security measures | Hepatoma | Index Medicus
Journal Article